• TaCRVP Hijacks Tomato Catalase to Suppress Defense

  2026-09-30

  A 2026 Advanced Science study identifies TaCRVP, a cysteine-rich venom protein in Tuta absoluta oral secretions, as an effector that targets tomato SlCAT2. The protein strengthens SlCAT2 activity and stability, suppresses hydrogen peroxide signaling, and weakens jasmonic acid-associated defenses that limit insect feeding.

• N-Formimidoyl Thienamycin vs New β-Lactams

  2026-09-30

  Cullmann et al. compared N-formimidoyl thienamycin with several contemporary β-lactams in 470 clinical isolates, emphasizing spectrum, bactericidal activity, and the influence of β-lactamase production. The study established strong activity against Pseudomonas aeruginosa and Acinetobacter spp. while showing that comparative performance varied substantially among Enterobacteriaceae.

• Toremifene Versus Tamoxifen in Advanced Breast Cancer

  2026-09-29

  The 2012 Cochrane review synthesized randomized evidence comparing toremifene with tamoxifen in advanced breast cancer and found no statistically significant difference in tumor response, time to progression, overall survival, or the reported adverse outcomes. Its main contribution is a clinically focused comparison showing that apparent similarity should be interpreted as comparative non-superiority, not proof that the two endocrine therapies are biologically identical.

• CPI-613: Metabolic Stress as an Assay Variable

  2026-09-29

  CPI-613, also known as 6,8-bis(benzylsulfanyl)octanoic acid, is examined here as a mechanistic tool rather than simply a cytotoxic reagent. This guide connects mitochondrial enzyme inhibition with PDHA1-driven metabolic plasticity and shows how to design more interpretable apoptosis assays and tumor cell metabolism studies.

• FOXN1 Reprogramming of Fibroblasts into Thymic Cells

  2026-09-28

  Ma and colleagues define how FOXN1 converts mouse embryonic fibroblasts into induced thymic epithelial cells, separating early and late transcriptional events during reprogramming. Their results identify proliferation, Notch suppression, and thymocyte co-culture as experimentally useful levers for improving iTEC maturation and MHCII expression.

• Macrophages Link Intermittent Hypoxia to Pain Priming

  2026-09-28

  In a mouse model of chronic intermittent hypoxia, both male and female mice developed persistent pain-related behaviors and evidence of nociceptor priming. The study links these changes to peripheral macrophage recruitment and reports that macrophage ablation prevented priming, identifying an immune contribution to pain associated with obstructive sleep apnea (OSA).

• Targeting Fructose Metabolism in Cancer Therapy

  2026-09-27

  This review connects dysregulated fructose uptake and metabolism with aggressive tumor behavior, including metabolic adaptation, mTORC1 signaling, and impaired antitumor immunity. Its integration of cancer-statistics analysis and mechanistic literature supports testing fructose-pathway targets, while leaving clinical benefit and patient selection to be established.

• From Poly(A) Capture to Resistance Biology

  2026-09-26

  How transcriptome and metabolite evidence can illuminate cisplatin resistance—and why thoughtful eukaryotic mRNA isolation is a foundational part of translational study design.

• MitMAB and the Meaning of EV Uptake

  2026-09-25

  MitMAB can help test whether extracellular-vesicle internalization depends on dynamin activity, but a reduced uptake signal is not the same as proof of intracellular delivery. This article connects MitMAB use to model orientation, measurement controls, and the interpretation of biological responses in intestinal stem cell systems.

• Trilaurin Protects Desmopressin During Lipid Digestion

  2026-09-25

  This study integrated lipid digestion and proteolysis in an in vitro model to examine how solid lipid microparticles affect desmopressin release and survival. Its key finding is that trilaurin can alter both processes: its effects depend on how it is incorporated and can include faster release alongside protection from proteolytic degradation.

• HATU Workflows for Selective Inhibitor Discovery

  2026-09-24

  Use HATU to assemble amide-linked analogs efficiently, then connect synthesis to a disciplined enzyme-selectivity workflow. A study of bestatin-derived aminopeptidase inhibitors shows why stereochemistry, matched enzyme panels, and cellular validation matter as much as coupling conversion.

• Uridine, Trisodium Salt in RNA-Directed Insertion

  2026-09-24

  PRINT points toward precise, RNA-templated genome insertion—but the role of a nucleotide precursor must be defined carefully. Explore where Uridine, Trisodium Salt fits, what the evidence supports, and how translational teams can validate the distinction between RNA production and RNA-guided insertion.

• FITC Goat Anti-Rabbit IgG in Fibrosis Assays

  2026-09-23

  Learn how the FITC Goat Anti-Rabbit IgG (H+L) Antibody can support spatial readouts in studies of interleukin-11 signaling and pulmonary fibrosis. This article connects a recent GP130-biased IL-11 study to practical assay design, emphasizing what fluorescence can—and cannot—show about target engagement and tissue response.

• BCL-XL Inhibitor A-1155463: Cancer Assays

  2026-09-23

  A practical guide to using the BCL-XL inhibitor A-1155463 for dependency mapping, apoptosis profiling, and exploratory tumor studies. The workflow emphasizes mechanism-based controls, DMSO-aware handling, and interpretation of platelet and resistance phenotypes.

• 5-Azacytidine in Multiple Myeloma: DNA Damage and Synergy

  2026-09-22

  This 2007 study showed that 5-azacytidine kills therapy-sensitive, therapy-resistant, and multidrug-resistant multiple myeloma cells while sparing peripheral blood mononuclear cells and bone marrow stromal cells at active concentrations. Its key innovation was linking DNA methyltransferase inhibition to ATR-dominant double-strand-break signaling, caspase-dependent and independent apoptosis, and synergistic activity with doxorubicin or bortezomib.

8599 records 1/574 page Next 12345 下5页 Last page